Skip to search formSkip to main contentSkip to account menu

MKNK1 protein, human

Known as: MAP Kinase Interacting Kinase 1, Mnk1, MAP Kinase-Interacting Serine/Threonine Kinase 1 
MAP kinase-interacting serine/threonine-protein kinase 1 (465 aa, ~51 kDa) is encoded by the human MKNK1 gene. This protein may play a role in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
An effective and durable T-cell response is a cornerstone of current immunotherapies. We show that eFT508, a potent, selective… 
2015
2015
To determine the effect of Newcastle disease virus(NDV) infection on host translation machinery and associated signaling pathways… 
2013
2013
esters, Ca2 and some G-protein-linked agonists activates Andrew Jan Waskiewicz1,2, Andrea Flynn3, the Erk cascade. This cascade… 
2013
2013
Despite decades of research, the function of sleep remains controversial. One theory is that sleep plays a role in consolidating… 
2013
2013
) ! /0 1 2 " " 3 " 4 & . * . " & ) ! " " ) ! . * % . ' 5. & 1 .+2 . !67& ) ! 1 .!2 55 " 1 .0-2 " " 10 * #8882* ! .0.0-" # 9 .0… 
2011
2011
The present invention can be influenced by inhibition of the kinase activity of novel thienopyrimidine compounds of general… 
2007
2007
The stress-activated protein kinases (SAPKs) consist of the c-Jun N-terminal kinases (JNKs or SAPK1αβγ) and of the four p38 MAPK… 
2007
2007
本発明は、チエノピリミジン化合物を含んで成る新規医薬組成物に関する。 さらに、本発明は、Mnk1および/またはMnk2(Mnk2aまたはMnk2b)および/またはそれらの変異体のキナーゼ活性の阻害に影響されうる疾患の予防および/または治療用の医薬組成物を製造するための、本発明のチエノピリミジン化合物の使用にも関する。 
2003
2003
Angiotensin II (Ang II) stimulates protein synthesis in vascular smooth muscle cells (VSMCs), possibly secondary to regulatory…